• 1
    Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am 1999; 28: 25581, vii.
  • 2
    Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997; 337: 102935.
  • 3
    Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002; 359: 15419.
  • 4
    Hanauer SB, Sandborn W. Management of Crohn's disease in adults. Am J Gastroenterol 2001; 96: 63543.
    Direct Link:
  • 5
    Fenton TR. A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format. BMC Pediatr 2003; 3: 13.
  • 6
    Simister NE. Placental transport of immunoglobulin G. Vaccine 2003; 21: 33659.
  • 7
    Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004; 350: 87685.
  • 8
    Baert F, Noman M, Vermeire S, et al. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N Engl J Med 2003; 348: 6018.
  • 9
    Srinivasan R. Infliximab treatment and pregnancy outcome in active Crohn's disease. Am J Gastroenterol 2001; 96: 22745.
    Direct Link:
  • 10
    James RLPL. Successful treatment of pregnancy-triggered Crohn's disease complicated by severe recurrent life-threatening gastrointestinal bleeding. Am J Gastroenterol 2001; 96: S295.
  • 11
    Bank LHB. Unexpected dramatic clinical response of psoriasis lesions and unexpected pregnancy in an infertile patient in response to treatment with anti-tumor necrosis factor monoclonal antibody for Crohn's disease. Am J Gastroenterol 2002; 97: S260.
  • 12
    Burt MJ, Frizelle FA, Barbezat GO. Pregnancy and exposure to infliximab (anti-tumor necrosis factor-alpha monoclonal antibody). J Gastroenterol Hepatol 2003; 18: 4656.
  • 13
    Dechant C, Antoni C, Wendler J, et al. One Year Outcome of Patients with Severe Psoriatic Arthritis Treated with Infliximab. Arthritis Rheum 2000; 43: 214.
  • 14
    Chakravarty EF, Sanchez-Yamamoto D, Bush TM. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes. J Rheumatol 2003; 30: 2416.
  • 15
    Kinder AJ, Edwards J, Samanta A, Nichol F. Pregnancy in a rheumatoid arthritis patient on infliximab and methotrexate. Rheumatology (Oxford) 2004; 43: 11956.
  • 16
    Lichtenstein G, Cohen RD, Feagan BG, et al. Safety of Infliximab in Crohn's disease: data from the 5000 – patient TREAT registry. Gastroenterology 2004; 126: A54.
  • 17
    Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 2004; 99: 238592.
    Direct Link:
  • 18
    Peltier M, James D, Ford J, et al. Infliximab levels in breast-milk of a nursing Crohn's patient. Am Coll Gastroenterol 2001; 96: P258.